Search Results - "HANGAISHI, Akira"
-
1
The effect of iron overload and chelation on erythroid differentiation
Published in International journal of hematology (01-02-2012)“…We investigated the mechanisms of hematopoietic disorders caused by iron overload and chelation, in particular, the inhibition of erythroblast differentiation…”
Get full text
Journal Article -
2
A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays
Published in Cancer research (Chicago, Ill.) (15-07-2005)“…We have developed a robust algorithm for copy number analysis of the human genome using high-density oligonucleotide microarrays containing 116,204…”
Get full text
Journal Article -
3
Prolonged neutropenia is a risk of oral adverse events-related sepsis but is not associated with prognosis of tooth extraction in hematopoietic stem cell transplant recipients: A retrospective study
Published in Journal of oral and maxillofacial surgery, medicine, and pathology (01-05-2023)“…Although the oral cavity has been identified as a potential site of infection in hematologic malignancies and oral adverse events (OAEs) have been reported to…”
Get full text
Journal Article -
4
Mental foramen in panoramic radiography can be a reference for discrimination of punched-out lesions in the mandible in patients with symptomatic multiple myeloma: A cross-sectional study
Published in Global Health & Medicine (30-06-2022)“…Multiple myeloma (MM) is a hematopoietic malignancy characterized by monoclonal proliferation of plasma cells. MM features bony radiolucencies called…”
Get full text
Journal Article -
5
Gain‐of‐function mutations and copy number increases of Notch2 in diffuse large B‐cell lymphoma
Published in Cancer science (01-05-2009)“…Signaling through the Notch1 receptor has a pivotal role in early thymocyte development. Gain of Notch1 function results in the development of T‐cell acute…”
Get full text
Journal Article -
6
-
7
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
Published in Haematologica (Roma) (01-12-2023)“…The incidence of second primary malignancies (SPM) in long-term survivors of multiple myeloma (MM) is increasing because of increased life expectancy. We…”
Get full text
Journal Article -
8
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
Published in International journal of hematology (01-06-2009)“…We investigated the role of therapeutic dose monitoring (TDM) in the treatment of fungal infections with voriconazole through 49 analyses of 34 patients who…”
Get full text
Journal Article -
9
-
10
Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation
Published in American journal of hematology (01-02-2022)“…We compared characteristics of myeloid neoplasms (MNs) following allogeneic hematopoietic cell transplantation (HCT) versus autologous HCT using a Japanese HCT…”
Get full text
Journal Article -
11
Highly Sensitive Method for Genomewide Detection of Allelic Composition in Nonpaired, Primary Tumor Specimens by Use of Affymetrix Single-Nucleotide–Polymorphism Genotyping Microarrays
Published in American journal of human genetics (01-07-2007)“…Loss of heterozygosity (LOH), either with or without accompanying copy-number loss, is a cardinal feature of cancer genomes that is tightly linked to cancer…”
Get full text
Journal Article -
12
The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-10-2021)“…Many articles have reported that the coronavirus disease 2019 (COVID-19) causes coagulation abnormalities and pulmonary thrombosis, contributing to a poorer…”
Get full text
Journal Article -
13
The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan
Published in Transfusion and apheresis science (01-06-2023)“…Since 2020, the novel coronavirus infection (COVID-19) has spread globally. A few studies have investigated the safety of COVID-19 convalescent plasma (CCP)…”
Get full text
Journal Article -
14
Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-09-2023)“…Convalescent plasma is a potential therapeutic option for patients with coronavirus disease 2019 (COVID-19). Despite its use for treating several viral…”
Get full text
Journal Article -
15
Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals
Published in Life (Basel, Switzerland) (01-11-2023)“…Convalescent plasma therapy, which involves administering plasma from recovered coronavirus disease 2019 (COVID-19) patients to infected individuals, is being…”
Get full text
Journal Article -
16
R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study
Published in Cancer science (01-10-2020)“…The efficiency of upfront consolidation with high‐dose chemotherapy/autologous stem‐cell transplantation (HDCT/ASCT) for newly diagnosed high‐risk diffuse…”
Get full text
Journal Article -
17
A Case of Recurrent Ovarian Cancer and Therapy-Related Acute Myeloid Leukemia Treated with Azacitidine
Published in Case reports in oncology (27-12-2021)“…Abstract Therapy-related myelodysplastic syndrome (tMDS) and acute myeloid leukemia (tAML) are lethal complications of chemotherapy. The incidence rates are…”
Get full text
Journal Article -
18
A novel protocol for de-isolating moderately and severely immunocompromised COVID-19 patients
Published in Global Health & Medicine (31-12-2023)“…Immunocompromised coronavirus disease 2019 patients are at a higher risk of prolonged viral shedding than immunocompetent patients. However, as of August 2023,…”
Get full text
Journal Article -
19
Novel Molecular Pathogenesis and Therapeutic Target in Acute Erythroid Leukemia
Published in Blood (13-11-2019)“…Acute erythroid leukemia (AEL) is a unique subtype of acute myeloid leukemia (AML) characterized by erythroid predominance and dysplasia, which is…”
Get full text
Journal Article -
20
Blimp-1 is a tumor suppressor gene in lymphoid malignancies
Published in International journal of hematology (01-01-2010)“…B lymphocyte-induced maturation protein (Blimp-1) is a transcriptional factor, which controls the terminal differentiation of mature B cells to plasma cells…”
Get full text
Journal Article